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  T
he Registrar General of 
India’s Sample Registration 
System (SRS), a large routine 
demographic survey, is the country’s 
primary system for the collection of 
fertility and mortality data (Box 1). It 
is widely regarded as an innovative way 
of capturing essential information on 
mortality patterns that may inﬂ  uence 
public health policy. However, 
although this monitoring system has 
been in place since 1971, there are 
relatively few evaluations to indicate 
if the SRS is truly representative or 
functional as a robust monitoring 
system. 
    The Million Death Study in India is 
an ambitious project being undertaken 
by the SRS in close collaboration with 
the Centre for Global Health Research 
at the University of Toronto, leading 
Indian and other overseas academic 
institutions, and the Indian Council 
of Medical Research. The study will 
use the SRS framework to obtain 
information, from a reasonably large 
cohort of deaths (1 million deaths 
over 16 years), on the underlying 
causes of child and adult deaths, as 
well as key risk factors for these deaths 
(behavioral, physical, environmental, 
and, possibly, genetic). In a new study 
in   PLoS Medicine  , Prabhat Jha and 
colleagues report on the rationale, 
design, and implementation of the 
Million Death Study in India [1].
    The study will use a combination 
of methods, looking at both a 
retrospective and a prospective cohort 
of deaths. These methods include case 
control studies, risk assessments, and 
genetic association studies. Given the 
unique characteristics of the health-
care system in India, and the country’s 
enormous double burden of infectious 
and noncommunicable diseases, 
the Million Death Study will provide 
valuable information for India that may 
also be relevant to other developing 
countries. 
    The researchers involved in the 
study have shown great foresight in 
making their protocols available for 
public scrutiny. It may, therefore, 
be worthwhile to ask a few pertinent 
questions at this early stage in the 
project.
    Is the “Large Sample” Truly 
Representative? 
    Is the SRS framework adequate for 
India’s current and future surveillance 
needs? While the scale of the study 
and the sample of 1 million deaths 
spanning the period 1998–2014 is 
daunting, one can see some limitations 
of this unique exercise given the 
population size and diversity in India. 
The study is largely embedded within 
the revised SRS framework, and 
capitalizes on the existing system. 
Although the new SRS sample frame is 
larger than before, the 7,597 sampling 
units cover only 7.6 million people 
out of India’s population of just over 1 
billion people. The new sample covers 
only half a million of an estimated 
annual 9.5 million deaths in India. 
    Public health surveillance and 
monitoring systems have a key role in 
local health policymaking, so it would 
have been valuable for the SRS to have 
given information with district-level 
speciﬁ  city. It is also unclear if the SRS 
sample covers pockets of deprivation 
in urban and periurban slums, where 
health care and health indicators are 
even worse than in rural populations 
[2]. Given the increasingly devolved 
health-care system, any surveillance 
and monitoring system must have local 
speciﬁ  city, and given the scope and 
timescale of the study, these issues 
are best addressed at the outset. This 
study could have been the stimulus to 
expand the SRS sample size to reﬂ  ect 
district level trends, as well as maternal 
mortality (a reduction in maternal 
mortality is an important Millennium 
Development Goal [MDG]). 
    The major limitation in terms of 
expanding the SRS is cost. The current 
study is being undertaken with an 
incremental budget of a mere US$2 
million. While the resources are clearly 
a limitation for this study, the low 
level of public health spending in the 
region nevertheless largely reﬂ  ects 
  The Million Death Study in India: Can It 
Help in Monitoring the Millennium 
Development Goals? 
  Citation:  Bhutta ZA (2006) The million death study 
in India: Can it help in monitoring the Millenium 
Development Goals? PLoS Med 3(2): e103.
   Copyright:   © 2006 Zulﬁ  qar A. Bhutta. This is an 
open-access article distributed under the terms 
of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original 
author and source are credited. 
   Abbreviations:  MDG, Millennium Development 
Goal; SRS, Sample Registration System 
  Zulﬁ  qar A. Bhutta is husein Laji Dewraj Professor 
and Chairman, Department of Paediatrics & Child 
Health, Aga Khan University, Karachi, Pakistan. E-mail: 
zulﬁ  qar.bhutta@aku.edu
   Competing  Interests:  The author has declared that 
no competing interests exist.
   DOI:  10.1371/journal.pmed.0030103 
The Perspectives section is for experts to discuss the 
clinical practice or public health implications of a 
published article that is freely available online.
  Box 1. Sample Frames of India’s 
SRS
    “There are two SRS sample frames. The 
ﬁ  rst SRS sample frame covers 6.3 million 
people (including 2.9 million adults 
aged 25 years or older) in all 28 states 
and seven union territories of India. An 
average of 150 households are drawn 
from each of 6,671 sample units (4,436 
rural and 2,235 urban), which in turn are 
selected using 1991 census data. The 
new SRS sample frame covers about 
7.6 million people (including 3.5 million 
adults aged 25 years or older) in all 28 
states and seven union territories of India. 
Households are drawn from 7,597 sample 
units (4,433 rural and 3,164 urban) 
selected from the 2001 census” [1]. 
Zulﬁ  qar A. BhuttaPLoS Medicine  |  www.plosmedicine.org 0164
misplaced priorities [3]. I would argue 
that perhaps the study itself might have 
been the impetus to expand the SRS 
sample to a more representative sample 
with the power to track important MDG 
indicators in all strata. 
    Is the Focus Appropriate? 
    The Million Death Study largely 
focuses on adult mortality and, as 
indicated by the authors, it may not 
have sufﬁ  cient power to address 
maternal mortality. This is unfortunate 
because the persistently high burden 
of maternal morbidity and mortality is 
a unique challenge for South Asia [4]. 
While the constraints of an adequate 
population sample for maternal 
mortality are understandable, it would 
have been useful to see a few more 
reproductive health indicators in the 
current repertoire of risk factors that 
the investigators intend to track. With 
the global health community now 
focusing on achieving the MDGs [5], 
it is important to critically review and 
expand the repertoire of studies on 
maternal and childhood mortality. 
India has a high burden of fetal 
malnutrition [6], so it is also important 
to strengthen the emerging evidence 
of the link between maternal and fetal 
malnutrition, childhood growth, and 
long-term adverse outcomes such as 
diabetes and premature cardiovascular 
disease [7–8]. It may be possible to 
include variables on size at birth and 
early growth parameters within the 
planned substudies of the Million 
Death Study, as these variables may 
be important correlates of adult-onset 
diseases and premature mortality. 
    Are the Tools Robust? 
    Although the validity of routinely 
monitoring health data by health-
system employees can be questioned, 
the proposed study will have additional 
components that will involve secondary 
analyses of the data by external 
staff. It would also be important to 
have protocols in place for regular 
external validation of the primary 
data. Previous evaluations have shown 
close concordance between the data 
on smoking and alcohol consumption 
generated by the Special Fertility and 
Mortality Survey (the baseline survey of 
the Million Death Study) [9] and the 
data from the National Family Health 
Survey 2 (the National Family Health 
Survey is a large-scale, multiround 
survey coordinated by India’s 
International Institute for Population 
Sciences) [10], suggesting that the SRS 
data are indeed robust. Nevertheless, 
such cross-checking of the primary 
SRS data would be necessary through 
additional periodic surveys. 
    The Million Death Study proposes 
to use verbal autopsy instruments, for 
example, recording details of deaths 
as reported by family or friends to a 
trained but nonmedical ﬁ  eldworker. 
Verbal autopsy instruments are already 
in use for recording SRS deaths, and 
they have been validated for adult 
mortality, except for those at the 
extremes of age. The infant and child 
verbal autopsy tool [11] referred to 
in the proposed study has not been 
validated for use within the neonatal 
period, and several modiﬁ  cations 
have been made to adapt it to such 
use [12–14]. Given that almost 50% of 
all infant deaths in India occur in the 
neonatal period [15], the validation 
of the verbal autopsy tool employed in 
the SRS is critically important. Such 
studies for validation of modiﬁ  ed 
neonatal verbal autopsy instruments 
are currently underway (S. Qazi, 
World Health Organization, personal 
communication). 
    While the current study plans 
to focus on the “usual suspects” in 
causing neonatal deaths, such as deaths 
due to birth asphyxia, prematurity, 
and serious infections, it is equally 
important to be aware of emerging 
issues in neonatal health. The high 
global burden of stillbirths, especially 
those that occur in the intrapartum 
period, has been recently recognized 
[16]. Given that these deaths may 
represent the hidden burden of 
birth asphyxia and perinatal care, 
it would be appropriate to evaluate 
the importance of fresh stillbirths in 
the current framework (the Million 
Death Study framework appears to 
exclude stillbirths). The same may 
apply to infant deaths relating to 
malformations such as neural tube 
defects [17], which may represent both 
widespread nutritional deﬁ  ciencies and 
genetic polymorphisms. The planned 
study offers a unique opportunity to 
capture the true burden of premature 
mortality and potentially decrease 
handicaps relating to perinatal events 
and congenital malformations, on 
which almost no data exist from large 
population settings. 
  Ethical  Considerations
    The planned inclusion of genetic 
studies and the setting up of bio-
banks (collections of samples of 
bodily substances that are, or can be, 
associated with personal data) are a 
welcome initiative, as these studies 
have important implications for public 
health preventive strategies [18]. 
However, the use of such tools and 
research must be strictly regulated 
by ethical guidelines and criteria, 
such as those developed by the 
Indian Council for Medical Research 
[19]. The ethical issues involved in 
the use of biological materials in 
population surveys are a subject of 
intense debate, and while there are 
few universally applicable guidelines 
[20], the Million Death Study offers 
an opportunity for progress in this 
dynamic ﬁ  eld. Although these ethical 
aspects are not fully elaborated in 
the current proposal, one hopes that 
the investigators will use the available 
opportunity to address them. While 
these ethical issues may be important in 
mortality studies, they are particularly 
germane to the planned nested case-
control studies. 
  Conclusion
    In summary, despite the questions I 
have raised above, the Million Death 
Study is one of the most important 
projects in population health, with the 
real potential of addressing priority 
issues in public health. The challenge 
is to ensure that the study is relevant 
to the MDG targets that India has 
set itself, and that it also informs 
public health policy as it evolves. 
Addressing this challenge may mean 
potentially increasing the sampling 
frame to make the data more relevant 
at the district level, and including 
additional maternal and newborn 
health indicators within the current 
repertoire. Pushing the envelope in an 
already large project at this stage may 
yield much greater dividends in due 
course.   
The challenge 
is to ensure that 
the study is relevant 
to the MDG targets 
that India has set itself.
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